The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes

The prevalence of type 2 diabetes mellitus (T2DM), which is associated with cardiovascular morbidity and mortality, is increasing worldwide. Although there have been advances in diabetes treatments that reduce microvascular complications (nephropathy, neuropathy, retinopathy), many clinical studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Gwang Sil, Park, Joong Hyun, Won, Jong Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599901/
https://www.ncbi.nlm.nih.gov/pubmed/31099200
http://dx.doi.org/10.3803/EnM.2019.34.2.106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599901/
https://www.ncbi.nlm.nih.gov/pubmed/31099200
http://dx.doi.org/10.3803/EnM.2019.34.2.106

Ejemplares similares